384 related articles for article (PubMed ID: 20152858)
1. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
2. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
3. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
4. New players in the fatty acyl ethanolamide metabolism.
Rahman IA; Tsuboi K; Uyama T; Ueda N
Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
[TBL] [Abstract][Full Text] [Related]
5. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
6. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
Mulder AM; Cravatt BF
Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
[TBL] [Abstract][Full Text] [Related]
8. Enzymological studies on the biosynthesis of N-acylethanolamines.
Ueda N; Tsuboi K; Uyama T
Biochim Biophys Acta; 2010 Dec; 1801(12):1274-85. PubMed ID: 20736084
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
[TBL] [Abstract][Full Text] [Related]
10. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
Kaczocha M; Glaser ST; Chae J; Brown DA; Deutsch DG
J Biol Chem; 2010 Jan; 285(4):2796-806. PubMed ID: 19926788
[TBL] [Abstract][Full Text] [Related]
11. Biosynthetic pathways of the endocannabinoid anandamide.
Okamoto Y; Wang J; Morishita J; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1842-57. PubMed ID: 17712822
[TBL] [Abstract][Full Text] [Related]
12. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.
Ueda N; Okamoto Y; Morishita J
Life Sci; 2005 Aug; 77(14):1750-8. PubMed ID: 15949819
[TBL] [Abstract][Full Text] [Related]
13. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
Bottemanne P; Muccioli GG; Alhouayek M
Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
[TBL] [Abstract][Full Text] [Related]
14. Biology of endocannabinoid synthesis system.
Wang J; Ueda N
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):112-9. PubMed ID: 19126434
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism.
Zhao LY; Tsuboi K; Okamoto Y; Nagahata S; Ueda N
Biochim Biophys Acta; 2007 Nov; 1771(11):1397-405. PubMed ID: 17980170
[TBL] [Abstract][Full Text] [Related]
16. Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines.
Tsuboi K; Tai T; Yamashita R; Ali H; Watanabe T; Uyama T; Okamoto Y; Kitakaze K; Takenouchi Y; Go S; Rahman IAS; Houchi H; Tanaka T; Okamoto Y; Tokumura A; Matsuda J; Ueda N
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158972. PubMed ID: 34033896
[TBL] [Abstract][Full Text] [Related]
17. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.
Ueda N; Tsuboi K; Uyama T
FEBS J; 2013 May; 280(9):1874-94. PubMed ID: 23425575
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.
Ueda N; Okamoto Y; Tsuboi K
Curr Med Chem; 2005; 12(12):1413-22. PubMed ID: 15974992
[TBL] [Abstract][Full Text] [Related]
20. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A
Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
